Biomarker-driven adjuvant targeted therapy for NSCLC-the ALCHEMIST trials
Bull Am Coll Surg
.
2015 Sep;100(9):25-7.
Authors
Geoffrey R Oxnard
,
Colleen Watt
,
Dennis Wigle
,
Judy C Boughey
PMID:
26455072
No abstract available
MeSH terms
Biomarkers*
Carcinoma, Non-Small-Cell Lung / drug therapy*
Clinical Trials as Topic
Humans
Lung Neoplasms / drug therapy*
Molecular Targeted Therapy*
Substances
Biomarkers